The Outcomes and Safety of Single-Agent Sorafenib in the Treatment of Elderly Patients with Advanced Hepatocellular Carcinoma (HCC)

BACKGROUND. With the aging population, hepatocellular carcinoma (HCC) in the elderly represents a significant health burden. We aimed to evaluate and compare the efficacy and tolerability of single-agent sorafenib in treating elderly patients with advanced HCC versus the younger population. METHODS....

詳細記述

保存先:
書誌詳細
主要な著者: Wong, Hilda, Tang, Yuen Fong, Yao, Tzy-Jyun, Chiu, Joanne, Leung, Roland, Chan, Pierre, Cheung, Tan To, Chan, Albert C., Pang, Roberta W., Poon, Ronnie, Fan, Sheung-Tat, Yau, Thomas
フォーマット: Artigo
言語:Inglês
出版事項: AlphaMed Press 2011
主題:
Geriatric Oncology
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3248771/
https://ncbi.nlm.nih.gov/pubmed/22135121
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2011-0192
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料